Cramer-Gesundheits-Consulting: PR successes

PR successes

Since our foundation in 1992, we have achieved different kinds of success for our clients in numerous areas of expertise. A selection below:

Abbott Diagnostica
With scientific consensus in the doctor’s fee scale

AOK Federal Association / BW – AOK discount agreements
AOK Federal Association / BW – AOK discount agreements
Paradigm shift in the health system

Azupharma
Generic Captopril becomes market leader as a result of communication with associations

Byk Gulden/Altana
Pantozol – the last one will be first

Fisons et al.
Consensus conference keeps fixed asthma combinations off the negative list

Genentech/Roche
Convince health insurance funds of the price-benefit-performance ratio of the genetically engineered product Pulmozyme

Jenapharm
Jenapharm
Right off the bat to market leadership position of Valette

Male hormone deficiency – a new indication established with PR

Lilly
Lilly
Cialis – the most successful launch in 2003

Lindopharm
Lindopharm
Comeback for Lindofluid

Merck
Merck
Overcoming the fear of cortisone

Iodine substitution: a win-win situation for patients, doctors and health policy makers

The climacterium as new business segment

Serono
PR secures reimbursement for fertility treatment

Valeant
Valeant
PR expands the market for scar treatment products

Anti-Aging with the cosmeceutical Kinerase

Wrigley
Pre-marketing for Wrigley’s Extra only with PR

Zeneca
ACE inhibitors are not pointless pseudo innovations

Contact

Cramer PR im Gesundheits-
wesen und Consultant GmbH
Rathausplatz 12-14
65760 Eschborn
Tel: +49 (0)6196 - 77 66 - 0
Fax: +49 (0)6196 - 77 66 - 216
Contact

© 2008 CGC Cramer-Gesundheits-Consulting GmbH Website credits Sitemap Data protection